Search filters

List of works by Cameron J Turtle

A novel polymer-conjugated human IL-15 improves efficacy of CD19-targeted CAR T-cell immunotherapy

scientific article published in 2023

ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells

scientific article published on 25 December 2018

Anti-HLA antibodies in recipients of CD19 versus BCMA-targeted CAR T-cell therapy

scientific article published in 2023

Augmentation of anti-tumor immunity by adoptive T-cell transfer after allogeneic hematopoietic stem cell transplantation

scientific article published on August 1, 2012

Autologous transplant vs chimeric antigen receptor T-cell therapy for relapsed DLBCL in partial remission

scientific article published in 2022

Cytomegalovirus Exposure in the Elderly Does Not Reduce CD8 T Cell Repertoire Diversity

scientific article published on 12 December 2018

Cytomegalovirus-specific T cells are primed early after cord blood transplant but fail to control virus in vivo

scientific article published on February 14, 2013

Factors associated with durable EFS in adult B-cell ALL patients achieving MRD-negative CR after CD19 CAR T-cell therapy

scientific article published on 06 February 2019

Genetically retargeting CD8+ lymphocyte subsets for cancer immunotherapy

scientific article published on January 14, 2011

HLA Engineering of Human Pluripotent Stem Cells

scientific article published on April 30, 2013

Impact of CD19 CAR T-cell product type on outcomes in relapsed or refractory aggressive B-NHL

scientific article published in 2022

Innate signals overcome acquired TCR signaling pathway regulation and govern the fate of human CD161hi CD8α+ semi-invariant T cells

scientific article published on July 25, 2011

Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor-modified T-cell therapy.

scientific article

Overlap and Effective Size of the Human CD8 + T Cell Receptor Repertoire

scientific article published on September 1, 2010

Phase I study protocol: NKTR-255 as monotherapy or combined with daratumumab or rituximab in hematologic malignancies

scientific article published in 2021

Reply

scientific article published on 23 March 2019

Severe cytokine release syndrome is associated with hematologic toxicity following CD19 CAR T-cell therapy

scientific article published on 01 April 2022

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events

scientific article published on 01 December 2020

The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells

scientific article published on 19 February 2019